Most patients with RA ‘have never heard of treat-to-target’
But an Australian survey shows there's readiness to consider the approach.
Tag: Musculoskeletal – Rheumatic disorders
Barrett’s oesophagus ‘common’ in women with systemic sclerosis
The largest study to date shows a prevalence of 13%.
New febuxostat trial douses cardiovascular alarm
Investigators hope results from the FAST trial will lead to a rethink of boxed warnings on the drug.
Study reassures on COVID-19 threat to rheumatology patients
Concern over elevated odds of severe disease might be unfounded, conference told.
Novel target for reducing flare in giant cell arteritis
An investigational monoclonal antibody that inhibits GM-CSF receptor alpha shows promise, researchers say.Â
JAK inhibitor ‘looks promising for ankylosing spondylitis’
A study shows improvements in patient pain and function with few serious adverse events, researchers say.
Warfarin might raise the risk of joint replacement: study
The analysis in people with AF suggests a NOAC might be the better option for those at risk of osteoarthritis, authors say.
JAK inhibitor ‘safe and effective’ for RA over 20 months
Extension trial in patients with inadequate response to methotrexate finds no new safety signals, researchers report.
Hydroxychloroquine shortages ‘hit patient health’
Up to a quarter of rheumatology patients were disadvantaged in some regions, a global survey suggests.
Can you put your finger on the cause of this swelling?
Pat is a 74-year-old retiree who presents with a red, swollen, painful index finger for several days.
